Robert Carey headshot
RC

Robert M. Carey

Dean Emeritus
Dean Emeritus
Unit: School of Medicine
Department: Department of Medicine, Endocrinology and Metabolism
Office location and address
450 Ray C Hunt Dr
Charlottesville, Virginia 22903
Biography

Dr. Robert M. Carey is a world renowned clinical endocrinologist and leader in the field of cardiovascular endocrinology. He is past recipient of the Distinguished Physician Award of The Endocrine Society and was President of The Endocrine Society 2008-9.

Dr. Carey is a general clinical endocrinologist with special expertise in the hormonal causes of high blood pressure, body fluid and electrolyte disturbances and adrenal disorders. Dr. Carey provides clinical care in general endocrinology, cardiovascular endocrinology, adrenal disease and hypertension. Dr. Carey provides a state-of-the-art approach to blood pressure problems, including ambulatory blood pressure monitoring and testing for mutations in genes causing hypertension.

Dr. Carey regularly sees patients with the following endocrinological problems: primary hypertension, drug resistant hypertension, secondary hypertension, diabetes with hypertension, renovascular hypertension, hyperlipidemia, adrenal mass lesions, primary aldosteronism, pheochromocytoma, Cushing’s syndrome, adrenal insufficiency, congenital adrenal hyperplasia, hypokalemia, hyperkalemia, hyponatremia, syndrome of inappropriate vasopressin secretion, diabetes insipidus, carcinoid syndrome, and neuroendocrine tumors. Dr. Carey provides a comprehensive approach to cardiovascular risk, including lipid disorders, the insulin resistance syndrome and diabetes mellitus. Dr. Carey works with a diabetes educator in the care of diabetes, and provides nutritional, exercise and other lifestyle recommendations that reduce cardiovascular risk.

Renal AT2 Receptors in Hypertension
Source: U.S. NIH Heart, Lung, And Blood Institute
January 01, 2021 – December 31, 2024
Primary Aldosteronism Subtypes: Pathophysiology and Steroid Signatures
Source: Board of Regents of the University of Michigan
January 07, 2021 – December 31, 2021
MD-PATH Molecular Mechanisms in Salt Sensitivity of Blood Pressure
Source: U.S. NIH Heart, Lung, And Blood Institute
June 01, 2016 – May 31, 2021
MD-INMD-EN Renal AT2 Receptors in Hypertension
Source: U.S. NIH Heart, Lung, And Blood Institute
April 01, 2016 – January 04, 2021
Research Training in Neuroendocrinology
Source: U.S. NIH Institute of Diabetes & Digestive & Kidne
September 01, 2010 – August 31, 2016
MD-PATH Dopamine and Angiotensin Receptor Interactions in Genetic Hypertension
Source: U.S. NIH Heart, Lung, And Blood Institute
September 30, 2009 – June 14, 2016
Renal AT2 Receptors in Hypertension
Source: U.S. NIH Heart, Lung, And Blood Institute
April 15, 2010 – March 31, 2014
MD-INMD Urinary Angiotensinogen Excretin in Normal Subjects and Patients with Diabetes
Source: Daiichi Sankyo, Inc
September 20, 2007 – November 22, 2013
Effects of aliskiren on urinary angiotensinogen and angiotensin II in type-2 diabetes
Source: Novartis Pharmaceuticals Corporation
May 18, 2010 – January 15, 2013